Literature DB >> 16251550

Potential for abuse of buprenorphine in office-based treatment of opioid dependence.

Theodore J Cicero, James A Inciardi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16251550     DOI： 10.1056/NEJM200510273531724

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Intravenous misuse of buprenorphine: characteristics and extent among patients undergoing drug maintenance therapy.

Authors:  Enrico Moratti; Hamid Kashanpour; Tiziana Lombardelli; Maria Maisto
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

2.  Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia.

Authors:  Aleksandar Kecojevic; Heather L Corliss; Stephen E Lankenau
Journal:  Int J Drug Policy       Date:  2015-04-07

3.  A urinalysis-based comparative study of treatment adherence on buprenorphine and buprenorphine/naloxone combination used as opioid substitution therapy.

Authors:  Yatan Pal Singh Balhara; Raka Jain
Journal:  Innov Clin Neurosci       Date:  2012-07

4.  Prevalence and correlates of street-obtained buprenorphine use among current and former injectors in Baltimore, Maryland.

Authors:  Becky L Genberg; Mirinda Gillespie; Charles R Schuster; Chris-Ellyn Johanson; Jacquie Astemborski; Gregory D Kirk; David Vlahov; Shruti H Mehta
Journal:  Addict Behav       Date:  2013-08-17       Impact factor: 3.913

Review 5.  [Misuse of opioid analgesics. An internet analysis].

Authors:  R Krüger; W Meißner; A Zimmer
Journal:  Schmerz       Date:  2014-10       Impact factor: 1.107

6.  Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.

Authors:  Alexander R Bazazi; Michael Yokell; Jeannia J Fu; Josiah D Rich; Nickolas D Zaller
Journal:  J Addict Med       Date:  2011-09       Impact factor: 3.702

7.  Consumer attitudes about opioid addiction treatment: a focus group study in New York City.

Authors:  Nancy L Sohler; Linda Weiss; James E Egan; Carolina M López; Jamie Favaro; Robert Cordero; Chinazo O Cunningham
Journal:  J Opioid Manag       Date:  2013 Mar-Apr

Review 8.  Buprenorphine Prescribing: To Expand or Not to Expand.

Authors:  Xiaofan Li; Daryl Shorter; Thomas R Kosten
Journal:  J Psychiatr Pract       Date:  2016-05       Impact factor: 1.325

Review 9.  Opioids and the treatment of chronic pain: controversies, current status, and future directions.

Authors:  Andrew Rosenblum; Lisa A Marsch; Herman Joseph; Russell K Portenoy
Journal:  Exp Clin Psychopharmacol       Date:  2008-10       Impact factor: 3.157

10.  Acceptability and Feasibility of a Mobile Health Application for Video Directly Observed Therapy of Buprenorphine for Opioid Use Disorders in an Office-based Setting.

Authors:  Margo E Godersky; Jared W Klein; Joseph O Merrill; Kendra L Blalock; Andrew J Saxon; Jeffrey H Samet; Judith I Tsui
Journal:  J Addict Med       Date:  2020 Jul/Aug       Impact factor: 3.702
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.